We observed a similar increase of antigen-specific CD8(+) T cells homing to MRF/magnet-treated Renca-HA tumor-DLNs as well, with approximately 20-fold increase in total number of HA-Tg-CD8(+) T cells in the DLNs as compared to either MRF or PBS groups (Fig. 4D). The gene discussed is CD8A; the disease is neoplasm.